Trial record 1 of 1 for:
amytrx
Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04313400 |
|
Recruitment Status :
Completed
First Posted : March 18, 2020
Last Update Posted : January 18, 2024
|
Sponsor:
Amytrx Therapeutics, Inc.
Collaborator:
Amarex Clinical Research
Information provided by (Responsible Party):
Amytrx Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 19, 2023 |
| Actual Study Completion Date : | January 2, 2024 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):